Ligand Pharmaceuticals Inc (LGND)
Other Income/Expenses (Net)
$55.71M
Quarterly · Period ending: · USD
LGND Other Income/Expenses (Net)
Latest reported$55.71Mperiod ending
Latest reported$55.71Mperiod ending
LGND Quarterly Other Income/Expenses (Net) (-$1.30M → $55.71M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
LGND other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 55,713,000 | |
| -41,627,000 | |
| 36,740,000 | |
| 86,206,000 | |
| 2,779,000 | |
| -13,964,000 | |
| -29,563,000 | |
| -9,482,000 | |
| -46,290,000 | |
| 110,459,000 | |
| 20,455,000 | |
| -15,222,000 | |
| 5,154,000 | |
| 41,331,000 | |
| 43,754,000 | |
| 13,000 | |
| -1,000 | |
| -11,277,000 | |
| -19,760,000 | |
| -447,000 | |
| -12,438,000 | |
| 1,049,000 | |
| -7,840,000 | |
| -15,359,000 | |
| 21,019,000 | |
| -34,203,000 | |
| 2,004,000 | |
| -14,713,000 | |
| -13,898,000 | |
| 16,170,000 | |
| -89,938,000 | |
| 55,864,000 | |
| 25,404,000 | |
| 18,271,000 | |
| 2,315,000 | |
| -4,422,000 | |
| -4,715,000 | |
| -4,023,000 | |
| -12,126,000 | |
| -4,255,000 | |
| -14,020,000 | |
| -5,525,000 | |
| -5,188,000 | |
| -1,313,000 | |
| 17,927,000 | |
| -3,423,000 | |
| -2,626,000 | |
| -2,631,000 | |
| -117,000 | |
| -2,950,000 | |
| -4,419,000 | |
| -1,045,000 | |
| 2,290,000 | |
| -2,562,000 | |
| -3,679,000 | |
| 1,270,000 | |
| -1,913,000 | |
| 66,000 | |
| 268,000 | |
| -757,000 | |
| 529,000 | |
| -1,891,000 | |
| 4,375,000 | |
| 4,239,000 | |
| 3,963,000 | |
| 1,311,000 | |
| -221,000 | |
| 281,000 | |
| 181,000 | |
| -164,000 | |
| -575,000 | |
| 221,000 | |
| -286,000 | |
| 401,000 | |
| -198,000 | |
| 1,502,000 | |
| 2,455,000 | |
| 2,960,000 | |
| -388,000 | |
| 265,000 | |
| 886,000 | |
| 123,415,000 | |
| -2,038,000 | |
| -3,769,000 | |
| -2,400,000 | |
| -2,682,000 | |
| 11,955,000 | |
| -2,889,000 | |
| -2,921,000 | |
| -2,813,000 | |
| -48,112,000 | |
| -2,893,000 | |
| -2,927,000 | |
| -7,757,000 | |
| -27,054,000 | |
| -260,000 | |
| -329,000 | |
| -2,267,000 | |
| -7,614,000 | |
| -196,000 |